ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Pittsburgh, PA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Overweight
Diabetic Foot
Foot Ulcer

Diabetes trials near Pittsburgh, PA, USA:

A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (SURPASS-EARLY)

This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...

Active, not recruiting
Type 2 Diabetes
Drug: Antihyperglycemic medication
Drug: Tirzepatide

Phase 4

Lilly
Lilly

Uniontown, Pennsylvania, United States and 89 other locations

New

in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...

Begins enrollment in 2 months
Diabetes Mellitus, Type 2
Drug: Orforglipron
Drug: Dulaglutide

Phase 3

Lilly
Lilly

Smithfield, Pennsylvania, United States of America and 70 other locations

The purpose of this study is to investigate the efficacy and safety of retatrutide compared with placebo in participants with Type 2 Diabetes...

Active, not recruiting
Type 2 Diabetes
Drug: Retatrutide
Drug: Placebo

Phase 3

Lilly
Lilly

Pittsburgh, Pennsylvania, United States and 79 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Active, not recruiting
Diabetes Mellitus, Type 1
Drug: Ritlecitinib
Drug: Abrocitinib 200 MG Oral Tablet

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Pittsburgh, Pennsylvania, United States and 29 other locations

The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....

Active, not recruiting
Type 1 Diabetes
Drug: VX-264

Phase 1, Phase 2

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 15 other locations

the treatment with the COMS One device in subjects with refractory diabetic foot ulcers (DFUs). The prospective randomized, double-blinded, ...

Enrolling
Diabetic Foot Ulcer
Device: COMS One device
Device: Sham device
Piomic Medical

McKeesport, Pennsylvania, United States and 28 other locations

The purpose of this study is to assess the safety and efficacy of SkinTE for treatment of Wagner grade 1 diabetic foot ulcers....

Active, not recruiting
Diabetic Foot
Biological: SkinTE
Other: Control

Phase 3

PolarityTE

East Liverpool, Ohio, United States and 22 other locations

parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D...

Enrolling
Type 1 Diabetes
Drug: Low Dose SAB-142
Other: Placebo

Phase 2

Sab Biotherapeutics

Pittsburgh, Pennsylvania, United States and 70 other locations

This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplan...

Enrolling
Type 1 Diabetes
Kidney Transplant
Biological: Biological/Vaccine

Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Pittsburgh, Pennsylvania, United States and 6 other locations

New

The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective a...

Not yet enrolling
Diabetes Mellitus, Type 2
Drug: UBT251
Drug: Semaglutide Placebo

Phase 2

Novo Nordisk
Novo Nordisk

Uniontown, Pennsylvania, United States and 68 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems